Explore how Nobel laureates Ilya Mechnikov and Paul Ehrlich revolutionized immunology, shaping modern medicine and public ...
This article explores how the role of regulatory T cells in immunological self-tolerance evolved from skepticism to Nobel ...
Myotonic dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy, affecting about 1 in 8,000 people.
A single signaling pathway controls whether immune cells attack or befriend cells they encounter while patrolling our bodies, ...
Global News - Inquirer.net on MSN
Nobel Winner Sakaguchi aims for effective cancer treatment
Japanese researcher Shimon Sakaguchi, one of the three winners of this year's Nobel Prize in Physiology or Medicine, has ...
News-Medical.Net on MSN
Over-contracted gut muscles drive gastrointestinal symptoms in myotonic dystrophy
Myotonic dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy, affecting about 1 in 8,000 people.
STOCKHOLM—Japanese scientist Shimon Sakaguchi highlighted how his discoveries in immune regulation could shape the future of ...
From influencing weight gain to supporting immune function, gut microbes do far more than digest food. They may even explain ...
Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...
The Chosun Ilbo on MSN
Japanese eye clinic closes for family's Nobel ceremony
A notice from an ophthalmologist in Japan, announcing the closure of their clinic to attend the Nobel Prize in Physiology or ...
Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...
STOCKHOLM—Japan's two newest Nobel laureates were awarded their medals at the 2025 Nobel Prize award ceremony here at the Stockholm Concert Hall on Dec. 10.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback